Market Overview

Cell Therapeutics to Join Russell 3000 and Russell Global Indexes on June 28, 2013

Share:

Cell Therapeutics (NASDAQ: CTIC) announced today that it is set to join the broad-market Russell 3000® and Russell Global Indexes when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 28, 2013, according to a preliminary list of additions posted on June 14, 2013 and available at www.russell.com/indexes. Annual reconstitution of Russell's U.S. indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well as the appropriate growth and value style indexes. Membership in the Russell Global Index, which remains in place for one year, means automatic inclusion in the appropriate large-cap, small-cap, all-cap indexes as well as the applicable style, sector and country indexes. Russell determines membership for its equity indexes primarily by objective, market capitalization rankings and style attributes.

Russell indexes are widely used by investment managers and institutional investors for index funds and

See full press release

Posted-In: News Guidance Contracts Asset Sales Management Global

 

Related Articles (CTIC)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial

Elan Shareholders did Not Approve Theravance, AOP, LND005 Transactions

ATK Awarded $50M Contract to Produce Composite Aft Fan Cases for Rolls-Royce Trent XWB-97